Stella Diagnostics Inc. (SLDX)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 6.19 Million USD | -22.14% |
| 2022 | 7.95 Million USD | 12.97% |
| 2021 | 7.04 Million USD | 444.68% |
| 2020 | 1.29 Million USD | -19.27% |
| 2019 | 1.6 Million USD | 2.64% |
| 2018 | 1.56 Million USD | 42.43% |
| 2017 | 1.09 Million USD | 0.0% |
| 2015 | 1.05 Million USD | 2.05% |
| 2014 | 1.03 Million USD | 101590.52% |
| 2013 | 1015.96 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 6.57 Million USD | 4.67% |
| 2024 Q1 | 6.28 Million USD | 1.5% |
| 2023 Q4 | 6.19 Million USD | 328.71% |
| 2023 Q3 | 1.44 Million USD | -76.17% |
| 2023 Q2 | 6.06 Million USD | 1.03% |
| 2023 Q1 | 6 Million USD | -24.56% |
| 2023 FY | 6.19 Million USD | -22.14% |
| 2022 Q3 | 203.22 Million USD | 2680.2% |
| 2022 FY | 7.95 Million USD | 12.97% |
| 2022 Q4 | 7.95 Million USD | -96.09% |
| 2022 Q2 | 7.3 Million USD | 1.35% |
| 2022 Q1 | 7.21 Million USD | 0.0% |
| 2021 FY | 7.04 Million USD | 444.68% |
| 2021 Q3 | 1.71 Million USD | 7.43% |
| 2021 Q2 | 1.59 Million USD | 0.0% |
| 2020 Q2 | 1.61 Million USD | 0.57% |
| 2020 Q1 | 1.6 Million USD | 0.0% |
| 2020 Q3 | 30.25 Thousand USD | -98.12% |
| 2020 FY | 1.29 Million USD | -19.27% |
| 2019 FY | 1.6 Million USD | 2.64% |
| 2018 Q1 | 1.09 Million USD | 0.0% |
| 2018 FY | 1.56 Million USD | 42.43% |
| 2017 FY | 1.09 Million USD | 0.0% |
| 2015 FY | 1.05 Million USD | 2.05% |
| 2014 FY | 1.03 Million USD | 101590.52% |
| 2013 FY | 1015.96 USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.2 Million USD | -180.737% |
| Arrayit Corporation | 1.05 Million USD | -486.697% |
| Atlantic International Corp. | 236.49 Thousand USD | -2518.674% |
| Biocept, Inc. | -788 Thousand USD | 885.921% |
| Bioqual, Inc. | -12 Million USD | 151.578% |
| CardioGenics Holdings Inc | 22.73 Thousand USD | -27135.406% |
| DermTech, Inc. | 17.65 Million USD | 64.918% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | 101.082% |
| HTG Molecular Diagnostics, Inc. | -7.37 Million USD | 183.952% |
| iMD Companies, Inc. | 1.11 Million USD | -454.976% |
| IDenta Corp. | 524.85 Thousand USD | -1079.963% |
| Interpace Biosciences, Inc. | 7.69 Million USD | 19.508% |
| Integrative Health Technologies, Inc. | -26.95 Thousand USD | 23078.106% |
| InVitro International | -313.14 Thousand USD | 2077.716% |
| Lumos Diagnostics Holdings Limited | 1.56 Million USD | -295.492% |
| Many Bright Ideas Technologies Inc. | -713.00 USD | 868691.725% |
| Medical Imaging Corp. | 3.79 Million USD | -63.365% |
| NovelStem International Corp. | 3.52 Million USD | -75.862% |
| Optigenex Inc. | 8.93 Million USD | 30.68% |
| PharmChem, Inc. | -1.49 Million USD | 514.414% |
| Proteome Sciences plc | 14.57 Million USD | 57.504% |
| Response Genetics, Inc | -13.08 Million USD | 147.326% |
| Rennova Health, Inc. | 14.82 Million USD | 58.239% |
| RushNet, Inc. | 4.8 Million USD | -28.999% |
| ScreenPro Security Inc. | 135.58 Thousand USD | -4467.523% |
| StageZero Life Sciences Ltd. | 1.78 Million USD | -247.067% |
| Todos Medical Ltd. | 38.31 Million USD | 83.836% |